A Randomized Investigator-blinded Comparative Study to Assess the Efficacy of the Cosmetic Care Product RV4133C - Formula JT2559 in Subjects With Facial Acne, During a 3-month-associated-treatment Phase Followed by a 3-month-maintenance Phase
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In this study, we are interested in the global benefit of the tested product as complementary care to a topical medical treatment during a 3 month-associated treatment phase followed by a 3 month-maintenance phase, compared to a light moisturizing cream, in teenagers and adults with acne. We also want to evaluate the tolerance of the tested product in association and in maintenance of the topical medical treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 24
Healthy Volunteers: f
View:
• Male or Female aged between 14 and 24 years (included)
• Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4.
• Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne
Locations
Other Locations
Brazil
UNIFESP
RECRUITING
São Paulo
Contact Information
Primary
Adeline Bacquey
adeline.bacquey@pierre-fabre.com
+33562877753
Backup
Christophe Chamard
christophe.chamard@pierre-fabre.com
+33562488566
Time Frame
Start Date: 2024-07-03
Estimated Completion Date: 2025-07-30
Participants
Target number of participants: 60
Treatments
Experimental: Test Group
Placebo_comparator: Comparative group
Related Therapeutic Areas
Sponsors
Leads: Pierre Fabre Dermo Cosmetique